17beta-(Acetylthio)estra-1,3,5(10)-trien-3-ol acetate



Compound IDCDAMM00160
Common name17beta-(Acetylthio)estra-1,3,5(10)-trien-3-ol acetate
IUPAC name[(8R,9S,13S,14S,17S)-17-acetylsulfanyl-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate
Molecular formulaC22H28O3S

Experimental data

Retention time27.64
Adduct[M+H]+
Actual mz373.183
Theoretical mz373.183
Error0.24
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score4.3984

Identifiers and class information

Inchi keyRVOGPLZAOZWWPL-AANPDWTMSA-N
SmilesCC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4SC(=O)C)C
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)3
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)372.521
Computed dipole moment(dipole)2.26
Total solvent accessible surface area (SASA)667.986
Hydrophobic component of SASA (FOSA)465.699
Hydrophilic component of SASA (FISA)88.557
Pie component of the SASA (PISA)93.769
Weakly polar component of the SASA (WPSA)19.961
Total solvent accesible volume (volume)1209.54
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4.5
Free energy of solvation of dipole (dip^2/V)0.0042242
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.821884
Predicted polarizability in cubic angstroms (QPpolrz)41.221
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.882
Predicted octanol/gas partition coefficient (QPlogPoct)15.791
Predicted water/gas partition coefficient (QPlogPw)6.345
Predicted octanol/water partition coefficient (QPlogPo/w)4.568
Predicted aqueous solubility (QPlogS)-6.118
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.203
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.861
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1432.56
Predicted brain/blood partition coefficient (QPlogBB)-0.442
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)938.505
Predicted skin permeability, log Kp (QPlogKp)-2.533
PM3 calculated ionization potential (IP(ev))9.38
PM3 calculated electron affinity (EA(eV))0.309
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)0.798
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)66.432
Number of nitrogen and oxygen atoms (#NandO)3
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P42330AKR1C3Aldo-keto-reductase family 1 member C3T60857SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P08185SERPINA6Corticosteroid binding globulinT88452SEA
P11511CYP19A1Cytochrome P450 19A1T13260SEA
P03372ESR1Estrogen receptor alphaT02506SEA
P33527ABCC1Multidrug resistance-associated protein 1T11288SEA
O95718ESRRBEstrogen-related receptor betaT42025SEA
P08842STSSteryl-sulfataseT33489SEA
Q9Y6L6SLCO1B1Solute carrier organic anion transporter family member 1B1T46814SEA
Q99527GPER1G-protein coupled estrogen receptor 1T65236SEA
O75751EMTHOrganic cation transporter 3T55948SEA
O15439ABCC4Multidrug resistance protein 4T39919SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T60857DI0145Female pelvic pain[ICD-11: GA34]P42330AKR1C3
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T88452DI0037Asthma[ICD-11: CA23]P08185SERPINA6
T88452DI0339Postoperative inflammation[ICD-11: 1A00-CA43]P08185SERPINA6
T88452DI0362Respiratory system disease[ICD-11: CB40-CB7Z]P08185SERPINA6
T13260DI0062Breast cancer[ICD-11: 2C60-2C6Y]P11511CYP19A1
T13260DI0108Cushing syndrome[ICD-11: 5A70]P11511CYP19A1
T02506DI0106COVID-19[ICD-11: 1D6Y]P03372ESR1
T11288DI0167Gout[ICD-11: FA25]P33527ABCC1
T33489DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]P08842STS
T65236DI0100Contraceptive management[ICD-11: QA21]Q99527GPER1

Copyright © 2025